Abstract:Coumarin derivatives have diverse structures and show various significant biological activities. Aiming to develop more potent coumarin derivatives for cancer treatment, a series of coumarin acrolein hybrids were designed and synthesized by using molecular hybridization approach, and investigated for their antiproliferative activity against A549, KB, Hela and MCF-7 cancer cells as well as HUVEC and LO2 human normal cells. The results indicated that most of the synthesized compounds displayed remarkable inhibitory activity towards cancer cells but low cytotoxicity on normal cells. Among all the compounds, 5d and 6e were the most promising compounds against different cancer cell lines, especially for A549 and KB cells. The preliminary action mechanism studies suggested that compound 6e , the representative compound, was capable of dose-dependently suppressing migration, invasion and inducing significant apoptosis. Furthermore, the combined results of network pharmacology and validation experiments revealed that compound 6e induced mitochondria dependent apoptosis via the PI3K/AKT-mediated Bcl-2 signaling pathway. In summary, our study indicated compound 6e could inhibit cell proliferation, migration, invasion and promote cell apoptosis through inhibition of PI3K/AKT signaling pathway in human oral epidermoid carcinoma cells. These findings demonstrated the potential of 3-(coumarin-3-yl)-acrolein derivatives as novel anticancer chemotherapeutic candidates, providing ideas for further development of drugs for clinical use.

Design, Synthesis and Biological Evaluation of Novel Betulinic Acid Derivatives.

Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents

Synthesis and Antitumor Activity of Novel 3-Oxo-23-hydroxybetulinic Acid Derivatives.

Design and Synthesis of Novel Betulin Derivatives Containing Thio-/Semicarbazone Moieties As Apoptotic Inducers Through Mitochindria-Related Pathways

Design, Synthesis and Biological Evaluation of a Series of New Resveratrol Analogues As Potential Anti-Cancer Agents

Synthesis and Biological Evaluation of Betulonic Acid Derivatives As Antitumor Agents.

Synthesis and Biological Evaluation of Oxygen-containing Heterocyclic Ring-fused 23-Hydroxybetulinic Acid Derivatives as Antitumor Agents.

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay

A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.

Design and Synthesis of NO-releasing Betulinic Acid Derivatives As Potential Anticancer Agents

Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives

Synthesis and in Vitro Antitumor Evaluation of Betulin Acid Ester Derivatives As Novel Apoptosis Inducers

Synthesis and Antiproliferative Evaluation of 23-Hydroxybetulinic Acid Derivatives

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirodihydrothiopyran-Oxindole Derivatives

Synthesis, Biological Evaluation and Mechanism Studies of C-3 Substituted Nitrogenous Heterocyclic 23-Hydroxybetulinic Acid Derivatives As Anticancer Agents

Synthesis and antitumor activity of 17-carboxylic acid modified amide derivatives of 23-hydroxy betulinic acid

Synthesis, Structure-Activity Relationships and Preliminary Antitumor Evaluation of Benzothiazole-2-Thiol Derivatives As Novel Apoptosis Inducers

Betulinic Acid and its Derivatives as Potential Antitumor Agents

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirotetrahydrothiopyran-Oxindole Derivatives As Potent P53-Mdm2 Inhibitors

Design, synthesis and biological evaluation of valepotriate derivatives as novel antitumor agents